BioSpace News Archive

Abcam plc, a global leader in the supply of life science research tools, notes that it has received a notice from Dr. Jonathan Milner seeking to require the Board of Directors to convene an Extraordinary General Meeting.

Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at several healthcare industry conferences in June 2023.

Neogen® Corporation announced that the Company will participate in the 43rd Annual William Blair Growth Stock Conference in Chicago, Illinois, on Tuesday, June 6, 2023.

LAVA Therapeutics N.V. announced the annual general meeting of shareholders will take place on Wednesday, June 14, 2023 at 2:00 p.m. CEST.

According to The Insight Partners market research study titled ‘Neurovascular Devices Market to 2027 – Global Analysis and Forecasts by Product, Application, End User and Geography, the global neurovascular devices market is expected to reach US$ 3,703.77 Mn in 2027 from US$ 2,744.26 Mn in 2019

According to our new market research study on “Typhoid fever vaccines Market to 2027 – Global Analysis and Forecas

The shareholders of Median Technologies are invited to participate at the Shareholders’ Ordinary and Extraordinary General Meeting which will be held on Tuesday June 20, 2023, at 11:00 AM CEST at PDGB, 174 avenue Victor Hugo – 75116 Paris.

Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) (“GENIX” or the “Company”) is pleased to report the results of the Annual General Meeting of shareholders held on May 18, 2023 (the “AGM”).

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today that it was awarded a $2 million Small Business Innovative Research (“SBIR”) grant from the National Cancer Institute (“NCI”).

The Insight Partners published latest research study on “Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Global Analysis